Home/Evommune/Lou Sehl, Ph.D.
LS

Lou Sehl, Ph.D.

Senior Vice President, Technical Operations

Evommune

Evommune Pipeline

DrugIndicationPhase
EVO756Chronic Spontaneous UrticariaPhase 2b
EVO301Atopic DermatitisPhase 2